TrialDiabetes & metabolism journal2019

Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea.

Yu Mi Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.